PMC:7795856 / 205-858
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
19 | 443-446 | Gene | denotes | Tα1 | Gene:134864 |
21 | 450-466 | Species | denotes | Escherichia coli | Tax:562 |
24 | 0-3 | Species | denotes | HBV | Tax:10407 |
25 | 385-386 | Chemical | denotes | N | MESH:D009584 |
26 | 402-406 | Chemical | denotes | RimJ | |
31 | 9-43 | Disease | denotes | hepatitis C virus (HCV) infections | MESH:D006526 |
32 | 122-130 | Disease | denotes | COVID-19 | MESH:C000657245 |
33 | 131-141 | Disease | denotes | infections | MESH:D007239 |
34 | 146-152 | Disease | denotes | cancer | MESH:D009369 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T3 | 9-18 | Phenotype | denotes | hepatitis | http://purl.obolibrary.org/obo/HP_0012115 |
T4 | 146-152 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 154-317 | Sentence | denotes | Manufacturing of this N-terminally acetylated 28-residue peptide is demanding, and its short plasma half-life limits in vivo efficacy and requires frequent dosing. |
T6 | 318-481 | Sentence | denotes | Here, we combined the PASylation technology with enzymatic in situ N-acetylation by RimJ to produce a long-acting version of Tα1 in Escherichia coli at high yield. |
T7 | 482-597 | Sentence | denotes | ESI-MS analysis of the purified fusion protein indicated the expected composition without any signs of proteolysis. |